These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2125736)

  • 1. Abnormal neuroendocrine responsivity to clomipramine in depression.
    Golden RN; Ruegg R; Brown TM; Haggerty J; Garbutt JC; Pedersen CA; Evans DL
    Psychopharmacol Bull; 1990; 26(3):317-20. PubMed ID: 2125736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antidepressant treatment with clomipramine on hormonal responses to thyrotropin-releasing hormone and insulin-induced hypoglycemia: implications for the "monoamine-hypothesis".
    Langer G; Karobath M; Sieghart W; Aschauer H; Placheta P; Spona J
    Pharmacopsychiatria; 1981 May; 14(3):100-6. PubMed ID: 6789342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central serotonergic changes following antidepressant treatment: a neuroendocrine assessment.
    Leatherman ME; Ekstrom RD; Corrigan M; Carson SW; Mason G; Golden RN
    Psychopharmacol Bull; 1993; 29(2):149-54. PubMed ID: 8290659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Different effects of tricyclic (clomipramine and amitriptyline) and tetracyclic (maprotiline) antidepressors on the release of thyroid stimulating hormone, prolactin and growth hormone to thyrostimulating releasing hormone in patients with psychoaffective disorders (author's transl)].
    Schlienger JL; Kapfer MT; Singer L; Stephan F
    Acta Psychiatr Belg; 1980; 80(5):584-99. PubMed ID: 6786002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of sub-chronic administration of hydrocortisone on hormonal and psychological responses to L-tryptophan in normal male volunteers.
    Porter RJ; Gallagher P; Watson S; Lunn BS; Young AH
    Psychopharmacology (Berl); 2002 Aug; 163(1):68-75. PubMed ID: 12185402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine effects of intravenous clomipramine in depressed patients and healthy subjects.
    Golden RN; Ekstrom D; Brown TM; Ruegg R; Evans DL; Haggerty JJ; Garbutt JC; Pedersen CA; Mason GA; Browne J
    Am J Psychiatry; 1992 Sep; 149(9):1168-75. PubMed ID: 1323933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antidepressant treatment on thyrotropin-releasing hormone stimulation, growth hormone response to L-DOPA, and dexamethasone suppression tests in major depressive patients.
    Esel E; Kartalci S; Tutus A; Turan T; Sofuoglu S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):303-9. PubMed ID: 14751427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of thyrotropin-releasing-hormone stimulation in patients with pituitary tumor.
    Cook DM; Greer MA; Paxton H
    West J Med; 1987 Aug; 147(2):161-4. PubMed ID: 3116772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A longitudinal study of serotonergic function in depression.
    Golden RN; Heine AD; Ekstrom RD; Bebchuk JM; Leatherman ME; Garbutt JC
    Neuropsychopharmacology; 2002 May; 26(5):653-9. PubMed ID: 11927190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin and cortisol responses to acute intravenous clomipramine challenge in patients with mania, depression and healthy controls: evidence for reduced serotonergic responsivity.
    Lykouras L; Markianos M; Hatzimanolis Y
    Neuropsychobiology; 2011; 63(2):77-81. PubMed ID: 21178381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mid-term effects of serial sleep deprivation therapy implemented in cognitive-behavioral treatment on the neuroendocrine response to clomipramine in patients with major depression.
    Kundermann B; Strate P; Hemmeter-Spernal J; Huber MT; Krieg JC; Lautenbacher S
    J Psychiatr Res; 2009 Apr; 43(7):711-20. PubMed ID: 18930473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary responses to thyrotropin releasing hormone in depressed patients: a review.
    Loosen PT; Prange AJ; Wilson IC; Lara PP
    Pharmacol Biochem Behav; 1976; 5(Suppl 1):95-101. PubMed ID: 827751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anger attacks in unipolar depression, Part 2: Neuroendocrine correlates and changes following fluoxetine treatment.
    Rosenbaum JF; Fava M; Pava JA; McCarthy MK; Steingard RJ; Bouffides E
    Am J Psychiatry; 1993 Aug; 150(8):1164-8. PubMed ID: 8328558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal neuroendocrine responsivity to acute i.v. clomipramine challenge in depressed patients.
    Golden RN; Hsiao JK; Lane E; Ekstrom D; Rogers S; Hicks R; Potter WZ
    Psychiatry Res; 1990 Jan; 31(1):39-47. PubMed ID: 2156276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic and dopaminergic neuroendocrine responses of male depressive patients before and after a therapeutic ECT course.
    Markianos M; Hatzimanolis J; Lykouras L
    Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):172-6. PubMed ID: 12242578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thyrotropin-releasing hormone in psychiatry: marker, predictor and therapeutical tool].
    Babinski T; Paunović VR
    Srp Arh Celok Lek; 1994; 122(11-12):341-3. PubMed ID: 17974414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine responses to L-tryptophan as an index of brain serotonin function: effect of weight loss.
    Anderson I; Cowen P
    Adv Exp Med Biol; 1991; 294():245-54. PubMed ID: 1722942
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroendocrine abnormalities in affective disorders.
    Extein I; Pottash AL; Gold MS
    Encephale; 1982; 8(2):203-11. PubMed ID: 6809445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin, cortisol secretion and thyroid function in patients with stroke of mild severity.
    Theodoropoulou A; Metallinos IC; Elloul J; Taleli P; Lekka N; Vagenakis AG; Kyriazopoulou V
    Horm Metab Res; 2006 Sep; 38(9):587-91. PubMed ID: 16981141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ; Utiger RD
    J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.